Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
基本信息
- 批准号:6610964
- 负责人:
- 金额:$ 36.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:3T3 cells G protein actins antisense nucleic acid apoptosis biological signal transduction bleomycin cell differentiation cell morphology collagen fibroblasts fibrogenesis gene expression genetic regulatory element integrins laboratory mouse lung injury messenger RNA phosphatidylinositol 3 kinase prostaglandins protein kinase protein tyrosine kinase pulmonary fibrosis /granuloma smooth muscle tumor necrosis factor alpha
项目摘要
The activation of myofibroblast is a central feature of interstitial pulmonary fibrosis. The objective of this proposal is to examine the regulation of the lung myofibroblast phenotype with an emphasis on the signal transduction pathways utilized by these cells to increase matrix deposition. Following lung injury in vivo, fibroblasts in the interstitial wall display a myofibroblast phenotype with increased expression of alpha-smooth muscle actin and alpha1(I) collagen mRNA. We have shown that prostaglandin E2 (PGE2) down-regulated steady state levels for alpha1(I) collagen, connective tissue growth factor and alpha- smooth muscle actin mRNA. PGE2 also stimulated Ca2+ activated K+ channels that decrease cell volume, and sensitized the cells to death receptor mediated apoptosis. These results indicate that PGE2 inhibits expression of the myofibroblast phenotype and has significant anti-fibrogenic properties. Preliminary data indicate that treatment of fibroblasts with PGE2 causes decreases in phosphatidylinositiol 3-kinase (PI-3K) as assessed by levels of phosphorylated protein kinase B/Akt. Employing inhibitors to PI-3K and mutant Akt constructs, we find that the activity of the PI-3K system regulates the stability of the alpha1(I) collagen mRNA. We hypothesize that fibroblast activation and the development of the myofibroblast phenotype involves an up- regulation in the activity of the PI-3K signal transduction pathways which in turn up-regulates alpha1(I) collagen and alpha- smooth muscle actin mRNA expression. PGE2 down-regulates these processes by affecting PI-3K activity and decreasing cell hydration. We plan to use cellular and molecular approaches to test our hypothesis in vitro and in vivo. Our studies will provide new insights into the regulation of the myofibroblast and suggest new therapeutic options for the treatment of pulmonary fibrosis.
肌成纤维细胞的活化是肺间质纤维化的中心特征。 本提案的目的是研究肺肌成纤维细胞表型的调节,重点是这些细胞增加基质沉积所利用的信号转导途径。 在体内肺损伤后,间质壁中的成纤维细胞表现出肌成纤维细胞表型,α-平滑肌肌动蛋白和α 1(I)胶原mRNA表达增加。 我们已经表明,前列腺素E2(PGE 2)下调α 1(I)胶原蛋白,结缔组织生长因子和α-平滑肌肌动蛋白mRNA的稳态水平。 PGE 2还刺激Ca ~(2+)激活的K ~+通道,使细胞体积减小,并使细胞对死亡受体介导的凋亡敏感。 这些结果表明,PGE 2抑制肌成纤维细胞表型的表达,并具有显着的抗纤维化特性。 初步数据表明,用PGE 2处理成纤维细胞引起磷脂酰肌醇3-激酶(PI-3 K)的降低,如通过磷酸化蛋白激酶B/Akt的水平所评估的。 采用PI-3 K和突变体Akt结构的抑制剂,我们发现PI-3 K系统的活性调节α 1(I)胶原mRNA的稳定性。 我们假设成纤维细胞活化和肌成纤维细胞表型的发展涉及PI-3 K信号转导途径活性的上调,其反过来上调α 1(I)胶原和α-平滑肌肌动蛋白mRNA表达。 PGE 2通过影响PI-3 K活性和降低细胞水合作用来下调这些过程。 我们计划使用细胞和分子的方法来测试我们的假设在体外和体内。 我们的研究将为肌成纤维细胞的调控提供新的见解,并为肺纤维化的治疗提供新的治疗选择。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Howard Goldstein其他文献
Ronald Howard Goldstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Howard Goldstein', 18)}}的其他基金
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8543292 - 财政年份:2013
- 资助金额:
$ 36.34万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8682796 - 财政年份:2013
- 资助金额:
$ 36.34万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
9794752 - 财政年份:2013
- 资助金额:
$ 36.34万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8794424 - 财政年份:2013
- 资助金额:
$ 36.34万 - 项目类别:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
他达拉非治疗与慢性肺病相关的肺动脉高压
- 批准号:
8967191 - 财政年份:2013
- 资助金额:
$ 36.34万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6787158 - 财政年份:2002
- 资助金额:
$ 36.34万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6920783 - 财政年份:2002
- 资助金额:
$ 36.34万 - 项目类别:
Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
- 批准号:
6466292 - 财政年份:2002
- 资助金额:
$ 36.34万 - 项目类别:
TYPE I COLLAGEN REGULATION IN PULMONARY FIBROSIS
肺纤维化中 I 型胶原蛋白的调节
- 批准号:
6411235 - 财政年份:2001
- 资助金额:
$ 36.34万 - 项目类别:
相似海外基金
Intelligent cryo-electron microscopy of G protein-coupled receptors
G 蛋白偶联受体的智能冷冻电子显微镜
- 批准号:
23K23818 - 财政年份:2024
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cryo-electron microscopy determination of G protein-coupled receptor states
冷冻电镜测定 G 蛋白偶联受体状态
- 批准号:
DE230101681 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Identifying reproductive roles for the Super-conserved Receptors Expressed in Brain (SREB) G protein-coupled receptor family using novel agonists and a comparative fish model
RUI:使用新型激动剂和比较鱼类模型确定脑中表达的超级保守受体 (SREB) G 蛋白偶联受体家族的生殖作用
- 批准号:
2307614 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Continuing Grant
Development of multidrug combination molecular targeted therapeutics based on G protein-coupled receptor interactions in glioblastoma
基于G蛋白偶联受体相互作用的胶质母细胞瘤多药组合分子靶向治疗的开发
- 批准号:
23K08551 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of Intermediate Conformations in G Protein-coupled Receptor Signaling
中间构象在 G 蛋白偶联受体信号传导中的作用
- 批准号:
10635763 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
India Link: Selective interactions between G protein-coupled receptors and conformationally selective arrestin variants
India Link:G 蛋白偶联受体与构象选择性抑制蛋白变体之间的选择性相互作用
- 批准号:
BB/T018720/1 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Research Grant
Architecture of inhibitory G protein signaling in the hippocampus
海马抑制性 G 蛋白信号传导的结构
- 批准号:
10659438 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Molecular mechanisms of GPCR/G protein diseases and drug development
GPCR/G蛋白疾病的分子机制及药物开发
- 批准号:
23K07998 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research Initiation Award: Exploring Class A G-Protein Coupled Receptors (GPCRs)-Ligand Interaction through Machine Learning Approaches
研究启动奖:通过机器学习方法探索 A 类 G 蛋白偶联受体 (GPCR)-配体相互作用
- 批准号:
2300475 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Standard Grant
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Research Grant